Union health minister Mansukh Mandaviya said on Saturday, Over the past eighteen months, India has commenced the production of 38 active pharmaceutical ingredients (APIs) that were previously reliant on imports
Speaking at the inaugural Healthcare Summit hosted by the Indian Institute of Management Ahmedabad (IIM-A), Mandaviya said this stride towards self-sufficiency was made possible through the implementation of the production-linked incentive (PLI) initiative within the pharmaceutical sector.
Mandaviya said that the impetus for a self-reliant strategy came in the aftermath of the 2017 border conflict with China in Doklam. This in turn prompted India to reassess its dependence on a single source for 95% of APIs used in the formulation industry, he added.
“In our efforts through the PLI scheme, we tried to eliminate the need for importing 54 APIs from foreign sources and instead promote domestic production for our formulation industry. Today, I’m pleased to announce that within just a year and a half, India has successfully initiated the manufacturing of 38 APIs, illustrating a prime instance of Atmanirbhar Bharat,” the Union health minister said.
https://www.hindustantimes.com/
